Vesalius Longevity Labs Company Description
Vesalius Longevity Labs Inc., together with its subsidiary, provides peptide-based therapeutics and wellness solutions in Europe, Middle East, North America, and internationally.
It develops and provides peptide-based therapies to support physiological functions, including metabolism, cognition, immune response, hormone regulation, and healthy aging.
The company also focuses on proactive, personalized care within the regenerative medicine and wellness sectors to address demands for therapies that promote long-term wellness and disease prevention.
Its products include injectable peptides; transdermal peptide patches; nasal and oral peptides; hydrogel technology; bioregulators; and topical peptide formulations.
The company serves healthcare providers, pharmaceutical companies, wellness clinics, and global distributors.
Vesalius Longevity Labs Inc. is based in Vancouver, Canada.
| Country | Canada |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| CEO | Pradeep Albert |
Contact Details
Address: 1055 West Georgia Street Vancouver, BC V6E 4N7 Canada | |
| Phone | 604 307 8290 |
| Website | vesaliuslabs.com |
Stock Details
| Ticker Symbol | VLAB |
| Exchange | Canadian Securities Exchange |
| Reporting Currency | CAD |
| ISIN Number | CA92490K1093 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Pradeep Albert | Chief Executive Officer |
| Christopher Cooper | Chief Financial Officer |
| Timmi Stump | Chief Operating Officer |